Skip to main content

Market Overview

R.F. Lafferty Devalues Auxilium, QLT Deal

Share:

R.F. Lafferty graded Auxilium Pharmaceuticals' (NASDAQ: AUXL) acquisition of QLT (NASDAQ: QLT) to be neutral, based on lack of sufficient cash for Auxilium to complete the deal.

Auxilium announced on Thursday that it will acquire QLT for 3.1359 shares of Auxilium stock, equivalent to a 25 percent premium based on QLT's stock price on June 25, 2014. The merger is expected to close later in the fourth quarter of 2014.
Despite the deal announced to be a stock-for-stock deal, Auxilium lacking the cash power could mean that acquiring QLT creates an opportunity cost, making the deal less valuable.

Shares of Auxilium dropped 3.93 percent to $20.43 in the middle of Thursday's market hours. Shares have rebounded in Friday's action, up less than one percent to $20.76.

Latest Ratings for AUXL

DateFirmActionFromTo
Oct 2014MizuhoDowngradesBuyNeutral
Oct 2014MKM PartnersDowngradesBuyNeutral
Sep 2014RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for AUXL

View the Latest Analyst Ratings

 

Related Articles (AUXL)

View Comments and Join the Discussion!

Posted-In: R.F. LaffertyAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com